the vaccine was 100% effective in preventing cervical intraepithelial neoplasia (CIN)1-3 and adenocarcinoma in situ (AIS) associated with HPV 16 and 18. In the FUTURE I intention-to-treat group ...
From 2008 to 2022, there were considerable decreases in the rates of cervical intraepithelial neoplasia (CIN) grades 2 to 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback